为分析中国人群非综合征性耳聋(Nonsyndromic hearing loss,NSHL)患者Cx26基因的突变情况和特性,研究其中两种突变的亚细胞定位情况,文章运用PCR直接测序的方法对139例无亲缘关系的NSHL患者进行突变筛查,将两种突变p.F115C和p.V37I构建到pEGFP表达载体,并转染Hela细胞,研究其细胞表达和定位情况。在139例无亲缘关系的NSHL患者中,31例患者检测到Cx26基因突变,检出率为22.3%。一共检测到10种不同类型的碱基变异,包括6种突变和4种多态,其中包括1种未见报道的新变异p.F115C。p.F115C和p.V37I两种突变体转染Hela细胞后,亚细胞定位情况与野生型无差异,初步研究表明这两种突变不影响该蛋白形成细胞间隙连接通道。
To analyze the frequencies and characteristics of Cx26 gene mutations in Chinese patients with nonsydromic hearing loss (NSHL) and investigate the intracellular localization of two mutants, 139 unrelated familial cases with non-syndromic hearing loss were screened for mutation in Cx26 gene by direct sequencing. Two mutants, p.F115C and p.V37I, were structured into pEGFP vectors and transfected into Hela cells to detect their expression and fluorescent localization in cells. Cx26 variations were detected in 31 patients, with a detection rate of 22.3%. The 10 variations included 6 types of mutations and 4 types of polymorphisms. A novel variation p.F115C was found. The fluorescent localization assay of the two mutants p.F115C and p.V37I showed no difference from the wild-type, indicating that both mutants did not impair the formation of the gap junctions